Search Results
Oct 14, 2025, 20:44 ET Nová Evropská koalice pro cirkulární textil vyzývá k vytvoření cirkulární textilní ekonomiky: „Svět bez odpadu je možný."
výrobních systémů. „Bez připravenosti systému hrozí, že i ty nejpokrokovější předpisy selžou. Jsme tu, abychom pomohli tuto mezeru překlenout," zdůrazňuje skupina. Manifest stanovuje tři klíčové pilíře politiky, které by mohly podpořit změnu:
More news about: Reju
Oct 14, 2025, 12:00 ET Descubre por qué el yoga es mejor entre el desierto y el mar de Baja California Sur
experiencias inmersivas diseñadas para transformar tu estilo de vida. El yoga es la clave para la renovación total. Más que una práctica física, es una herramienta de poder transformador diseñada para nutrir tu alma, energizar tu cuerpo y llevarte a un bienestar integral a través
More news about: Fideicomiso de Turismo de Baja California Sur
Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: BioArctic
Oct 14, 2025, 03:02 ET 포티크 호텔 나트랑, 월드 트래블 어워즈에서 '2025 베트남 최고의 라이프스타일 호텔'로 첫 선정
www.potiquehotel.com/kr에서 확인할 수 있다. 미디어 문의 응우옌 호앙 캄 투(Nguyen Hoang Cam Tu)마케팅 커뮤니케이션 매니저이메일: [email protected]
More news about: Potique Hotel Nha Trang
Oct 14, 2025, 01:18 ET Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: BioArctic
Oct 14, 2025, 01:14 ET Leqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: BioArctic
Oct 14, 2025, 01:03 ET ADO celebra 14 años de Caravana Rosa con un incremento del 14% en mastografías gratuitas
/PRNewswire/ -- ADO, empresa líder en transporte terrestre de pasajeros, anuncia la décimo cuarta edición de Caravana Rosa, bajo el lema "Primero tú, después todo". Esta iniciativa continúa promoviendo la detección oportuna del cáncer de mama mediante la entrega de mastografías gratuitas.
More news about: ADO
Oct 13, 2025, 21:23 ET Potique Hotel Nha Trang Honored for the First Time as "Vietnam's Leading Lifestyle Hotel 2025" at the World Travel Awards
www.potiquehotel.com. Media EnquiriesNguyen Hoang Cam TuMarcom ManagerE-mail: [email protected]
More news about: Potique Hotel Nha Trang
Oct 13, 2025, 19:30 ET LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: Eisai Inc.
Oct 10, 2025, 19:32 ET KATE SPADE NEW YORK HOSTED FOURTH ANNUAL GLOBAL SUMMIT ON WOMEN'S MENTAL HEALTH WITH SPEAKERS TARA DAVIS-WOODHALL, ALYSON STONER, AMAYA ESPINAL, JOY WOODS AND MORE. THE SUMMIT SHINED LIGHT ON BRAND'S GLOBAL FUND FOR WOMEN'S MENTAL HEALTH GOAL TO REACH 250,000 WOMEN AND GIRLS WITH ACCESS TO COMMUNITY-CENTRIC MENTAL HEALTH SERVICES BY 2030
Vivian Tu (NYT Best Selling Author and CEO of Your Rich BFF),
More news about: Kate Spade New York
Oct 10, 2025, 13:41 ET Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
Kopp, Founder of KFD. The keynote presentation, "Leadership and Success Augmented Through Adversity and Ingenuity," delivered by Dr. Conan Tu, traced the 100-year history of insulin's development and the human perseverance that shaped modern diabetes care. The program featured insights
More news about: Kopp Foundation for Diabetes
Oct 10, 2025, 13:00 ET Campaña "Libres para Ser" de Fondo Semillas gana el Napolitan Victory Award 2025 a Mejor Campaña ONG
2012. Construimos, posicionamos y protegemos la imagen, marcas y reputación de nuestros clientes y generamos valor al mejorar tu ambiente social y de negocios.
More news about: Fondo Semillas
Oct 09, 2025, 15:57 ET Las fiestas tienen un nuevo protagonista: OPPO lanza el Reno14 "Party Essential"
brindando tecnología que no solo sea de utilidad, sino que los inspire". Un diseño que forma parte de tu outfit Durante años, el diseño de smartphones se ha mantenido en un minimalismo discreto. En OPPO,
More news about: OPPO Mexico
Oct 09, 2025, 10:09 ET Una era en la que la meditación se convierte en un logro cuantificable: el primer "Desafío de meditación cuantificada" de Japón
"Comencé a meditar debido a una enfermedad hace casi dos décadas y he practicado todos los días desde entonces", dijo. "Si te sientes estresado y ansioso en tu vida, espero que la meditación te lleve a la paz interior como lo hizo conmigo". Ikigai y la ciencia del
More news about: World Meditation League (WML)
Oct 09, 2025, 09:05 ET Kimberly-Clark začína posilňovať globálne partnerstvá s cieľom zlepšiť základnú starostlivosť o 24 miliónov žien a dievčat
Celú interaktívnu tlačovú správu pre viacero kanálov si môžete pozrieť tu:
More news about: Kimberly-Clark Corporation
Oct 08, 2025, 14:56 ET Notizie Artprice: in vista di Frieze London e Art Basel Paris, Artprice by Artmarket pubblica il suo Contemporary Art Market Report 2025. Numero record annuale di transazioni d'asta, sostanziale mutamento di paradigma del mercato, influenze dell'intelligenza artificiale
47.000 artisti contemporanei in tutto il mondo (da luglio 2024 a giugno 2025), questo rapporto si è da tempo affermato come la Bibbia del settore. Che tu sia un professionista, un collezionista esperto, un giornalista, un appassionato o uno studente, questo rapporto rivela le tendenze, i cambiamenti strutturali
More news about: Artmarket.com
Oct 08, 2025, 13:53 ET APERTUM HOLDING NAJÍMA SPOLOČNOSŤ QUINN EMANUEL, ABY NAPADLA VAROVANIE ÚRADU BAFIN VO VZŤAHU K PLATFORME DAO1
rokov za „najobávanejšiu" právnickú firmuv rámci svojho výročného sprievodcu „Najobávanejšie právnické firmy v súdnych sporoch", kde interní právnici tu menovali firmy, ktorým sa „chcú v súdnych sporoch vyhnúť". Spoločnosť Chambers & Partners udelila spoločnosti Quinn Emanuel na udeľovaní cien
More news about: Quinn Emanuel Urquhart & Sullivan, LLP
Oct 08, 2025, 11:00 ET TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact
clinically validated and sustainably produced. "Our Spark drives us to innovate with creativity, action, and impact," said Jessica Tu, Chief Sustainability Officer at TCI Biotech. "These achievements demonstrate that sustainability is not separate from business, it is the foundation
More news about: TCI; TCI Biotech
Oct 08, 2025, 07:01 ET Alzheimer's Association and Edward Jones Extend Strategic Alliance Through 2030
POINTER Study, the International Research Grant Program, and the Alzheimer's Association International Conference (AAIC). The firm also co-funds the DIAN-TU Next Generation, High-Dose Escalation, and Primary Prevention studies, and supports early-career dementia researchers at Washington University School
More news about: Alzheimer's Association
Oct 07, 2025, 23:47 ET 越南KCN啟動安發項目，擴大越南北部現代化工業地產供應
未來，越南KCN集團計劃進一步擴充投資組合，力爭成為越南工業地產領域的領軍平台。其長遠目標是成為企業的首選合作伙伴，在越南邁向全球可持續工業中心的進程中扮演關鍵角色。 越南KCN集團已連續三年（2023-2025年）被《Nhip Cau Dau Tu》雜志評選為「最佳工業地產開發商」，2024年還躋身「可持續發展企業50強」。此外，在2023年BCI亞洲大獎評選中，該集團榮登「越南十大領先房地產開發商」榜單。
More news about: 越南KCN
Oct 07, 2025, 17:22 ET El primer "Desafío de Meditación Cuantificada" de Japón
Tras el desafío, el neurocientífico Prof. Ken Mogi, autor de El Pequeño Libro del Ikigai, ofreció una conferencia magistral titulada "Encuentra tu Ikigai con la Meditación Cuantificada". "Al combinar la meditación tradicional con la tecnología más avanzada, abrimos nuevas
More news about: World Meditation League (WML)
Oct 07, 2025, 13:26 ET IMG Saxony-Anhalt Takes the Stage at Semicon West in Phoenix - Showcasing Europe's Next Frontier for High-Tech Innovation
FMC: New Chip Factory in Sülzetal near Magdeburg Ferroelectric Memory Company (FMC), a TU Dresden spin-off, plans to build a memory chip plant in Sülzetal with an investment volume of around €3 billion, partially supported by public funding.
More news about: IMG - Investitions- und Marketinggesellschaft Sachsen-Anhalt
Oct 07, 2025, 09:17 ET Autonomía a escala: PassiveLogic y Aroundtown se asocian para transformar el sector inmobiliario europeo
construir infraestructuras generativas autónomas en minutos y colaborar fácilmente con agentes de IA mediante un conjunto intuitivo de herramientas "elige tu propia aventura". La empresa está aprovechando una oportunidad generacional para reinventar la automatización de edificios, reemplazando
More news about: PassiveLogic
Oct 06, 2025, 18:05 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: BioArctic
Oct 06, 2025, 18:02 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.
More news about: BioArctic